- Home
- CGTX vs PROP Comparison
CGTX vs PROP Comparison
Compare CGTX & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGTX | PROP |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.6M | 70.1M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CGTX | PROP |
|---|---|---|
| Price | $1.07 | $0.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $3.33 | ★ $6.75 |
| AVG Volume (30 Days) | 764.8K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.79 | 49.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,939,000.00 |
| Revenue This Year | N/A | $81.83 |
| Revenue Next Year | N/A | $18.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 413.59 |
| 52 Week Low | $0.55 | $0.58 |
| 52 Week High | $3.83 | $3.75 |
Technical Indicators
Market Signals| Indicator | CGTX | PROP |
|---|---|---|
| Relative Strength Index (RSI) | 59.33 | 49.08 |
| Support Level | $1.02 | $0.68 |
| Resistance Level | $1.19 | $0.86 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 92.59 | 38.38 |
Price Performance
Historical ComparisonAbout CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).
About PROP Prairie Operating Co.
Prairie Operating Co is an independent oil and natural gas company focused on the acquisition and development of crude oil, natural gas, and natural gas liquids (NGLs). Its assets and operations are located in the oil region of rural Weld County, Colorado, within the Denver-Julesburg Basin in Colorado (the DJ Basin). The company generates maximum revenue from crude oil sales, and the rest from the sale of natural gas and natural gas liquids.